News
-
-
-
COMMUNIQUÉ DE PRESSE
Amin Wasserman Gurnani Welcomes Former Acting Director for FDA's Office of Dietary Supplement Programs as Co-Chair of the Firm's Regulatory Group
Robert Durkin appointed as co-lead of regulatory practice at Amin Wasserman Gurnani alongside Rend Al-Mondhiry in Washington, D.C., bringing extensive FDA experience and strategic insight
